Search Results Search Sort by RelevanceMost Recent Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542. Case and Commentary Oct 2023 Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units? Alex Rollo, MD, Jeena Kar, DO, Uma Suryadevara, MD, and Mary Camp, MD This commentary considers how to manage agitation in patients with dementia. AMA J Ethics. 2023;25(10):E725-732. doi: 10.1001/amajethics.2023.725. Medicine and Society Oct 2023 Prioritizing Diversion and Decarceration of People With Dementia Lay Kodama, MD, PhD, Brie Williams, MD, MS, and Nathaniel P. Morris, MD An aging prison population means more people who are incarcerated will experience dementia and related symptoms. AMA J Ethics. 2023;25(10):E783-790. doi: 10.1001/amajethics.2023.783. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2
Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.
Case and Commentary Oct 2023 Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units? Alex Rollo, MD, Jeena Kar, DO, Uma Suryadevara, MD, and Mary Camp, MD This commentary considers how to manage agitation in patients with dementia. AMA J Ethics. 2023;25(10):E725-732. doi: 10.1001/amajethics.2023.725.
Medicine and Society Oct 2023 Prioritizing Diversion and Decarceration of People With Dementia Lay Kodama, MD, PhD, Brie Williams, MD, MS, and Nathaniel P. Morris, MD An aging prison population means more people who are incarcerated will experience dementia and related symptoms. AMA J Ethics. 2023;25(10):E783-790. doi: 10.1001/amajethics.2023.783.